Measures of Bacterial Endotoxins in Gingival Crevicular Fluid and Peripheral Blood of Aggressive Periodontitis Cases—A Clinical Association Authors: Akanksha Kashyap, Brijendra Singh, Srishti Shankar, Atul Gupta, Piyush Gowrav, Mohammad Arif Khan Published: 2024 ABSTRACT ABSTRACTIntroduction:The present study was undertaken with the objective to evaluate the level of endotoxin produced in the gingival crevicular fluid (GCF) and peripheral blood of subjects with generalized aggressive periodontitis (GAgP) in comparison with periodontally healthy subjects at baseline, three months, and six months post-periodontal surgical treatment.Materials and Methods:A total of 24 subjects aged between 20 and 50 years were selected for the study. They were divided into two groups: generalized aggressive periodontitis (GAgP) subjects (Group A) and periodontally and systemically healthy individuals (Group B). Endotoxin levels were assessed in GCF and peripheral blood of both the groups at baseline, three months, and six months postsurgical treatment. The clinical parameters, such as plaque index (PI), gingival index (GI), probing pocket depth (PPD), and clinical attachment level (CAL), were also recorded at same time intervals. A correlation between the clinical parameters and endotoxin in GCF and peripheral blood was established in diseased cases as compared to healthy individuals.Results:Favorable clinical outcomes with the reduction of PI, GI, PPD, and CAL were achieved for Group A post-surgery when compared to baseline. The GCF endotoxin level in Group A was observed to be significantly higher than Group B and reduced favorably after treatment. In peripheral blood, there was no significant difference in endotoxin level between both the groups.Conclusion:It can be concluded from the results that the level of bacterial endotoxin was significantly raised in GCF, indicating its role in the causation of rapid destruction of the periodontium in aggressive periodontitis subjects. INTRODUCTION Periodontitis is an inflammatory disease affecting the supporting tissues of the teeth, caused by specific microorganisms, leading to the destruction of the periodontal ligament and alveolar bone, resulting in pocket formation or gingival recession. While prevalent in adults, periodontitis can occur at any age and is usually associated with plaque and calculus. The understanding of periodontitis is evolving, revealing it as a family of related diseases that differ in etiology, progression, and therapy response but share common pathogenic events influenced by genetic and environmental modifiers. These modifiers interact with microbial challenges, creating a complex clinical picture. Some patients exhibit significant periodontal tissue loss at a young age or rapidly, categorized as “aggressive periodontitis” (AgP), a term finalized in 1999.[1] AgP, less common than chronic periodontitis, occurs in systemically healthy individuals and differs by age of onset, rapid progression, immune response alterations, and familial patterns.[2] It is characterized by specific subgingival microflora, notably Aggregatibacter actinomycetemcomitans[3] and Porphyromonas gingivalis,[4] which possess virulence factors, such as leukotoxins and endotoxins, i.e., lipopolysaccharides (LPS)[5] that modulate host responses and contribute to tissue destruction. Recent studies have linked systemic dissemination of LPS to periodontal disease, suggesting that elevated levels of Gram-negative bacteria and LPS activate inflammatory mediators, perpetuating the inflammatory cycle of periodontal disease.[6] Theories about the pathogenesis of aggressive periodontitis have evolved from viewing it as purely plaque-associated to emphasizing the host’s response to bacteria. MATERIALS AND METHODS This six-month case-controlled clinical and in vitro study was conducted to evaluate the levels of bacterial endotoxin in the gingival crevicular fluid (GCF) and peripheral blood of subjects with generalized aggressive periodontitis (GAgP). The study took place at the Department of Periodontics, Babu Banarasi Das College of Dental Sciences, Lucknow, in collaboration with the In Vitro Toxicology Laboratory, Indian Institute of Toxicology Research (IITR), Lucknow. Twenty-four volunteers, including 12 GAgP patients and 12 periodontally healthy individuals, were selected based on specific inclusion and exclusion criteria. The selection criteria included Indian adults aged between 20 and 50 years with a minimum number of natural teeth, specified probing pocket depth, and clinical attachment levels. Exclusion criteria encompassed smokers, pregnant women, individuals with systemic diseases affecting periodontal health, and those who had received recent antibiotic or periodontal treatment. All participants provided written informed consent after being briefed about the study protocol. Clinical parameters were recorded at baseline, three months, and six months posttreatment to evaluate periodontal status. These included plaque index (PI), gingival index (GI), probing pocket depth (PPD), and clinical attachment level (CAL). GCF samples were collected from the deepest periodontal pockets using absorbent paper points, while peripheral blood samples were obtained through venipuncture. Both GCF and blood samples were analyzed for endotoxin levels using the Limulus amebocyte lysate (LAL) test. For GAgP subjects, a comprehensive periodontal treatment was provided, which included phase-I therapy, flap surgery, and postoperative care. Antibiotics, anti-inflammatory drugs, and chlorhexidine mouth rinse were prescribed to enhance healing and maintain oral hygiene. The analysis was conducted using SPSS software version 16.0. RESULTS The study evaluated the impact of treatment on various periodontal indices over six months. Group A demonstrated a statistically significant reduction in the plaque index, decreasing from 1.69 ± 0.67 at baseline to 0.67 ± 0.11 at six months (P < 0.05). By the six-month mark, Group A’s plaque index was significantly lower than that of Group B (1.46 ± 0.98, P = 0.03). Similarly, the gingival index in Group A showed a significant reduction from baseline to three and six months (P < 0.05), with scores remaining consistently lower than those in Group B during this period. In terms of probing pocket depth (PPD), Group A experienced a significant decrease from 7.35 ± 2.34 at baseline to 3.19 ± 1.12 at six months (P < 0.05). Initially, Group A had higher PPD than Group B, but significant improvements were observed throughout the study [Table 1]. Table 1Endotoxin Level Comparison. Comparison (p) of gingival crevicular fluid (GCF) and peripheral blood endotoxin concentration (ng/ml) between Group A and Group B at baseline, three months, and six months, along with intragroup comparison within Group AVariableGroup AGroup BP¹ GCFPeripheral bloodGCFPeripheral bloodGCFPeripheral bloodBaseline4.71±1.570.56±0.510.33±0.700.49±0.380.001*0.073 months0.36±0.120.51±0.490.33±0.700.49±0.380.110.176 months0.08±0.020.45±0.390.33±0.700.49±0.380.002*0.13Group A—Baseline to 3 months²0.090.49±0.380.0001*0.07Baseline to 6 months²0.04*0.49±0.380.0001*0.17Three months to 6 months²0.070.49±0.380.002*0.13¹Mann–Whitney U test, ²Wilcoxon rank-sum test, *Significant Endotoxin Level Comparison. Comparison (p) of gingival crevicular fluid (GCF) and peripheral blood endotoxin concentration (ng/ml) between Group A and Group B at baseline, three months, and six months, along with intragroup comparison within Group A ¹Mann–Whitney U test, ²Wilcoxon rank-sum test, *Significant The clinical attachment level (CAL) in Group A also showed a notable improvement, with a significant decrease from baseline to six months (P = 0.03). Despite starting with higher CAL levels than Group B, Group A exhibited significant progress over the course of the study. In contrast, peripheral blood endotoxin levels did not show significant differences between the groups at any time point, although Group A experienced a significant decrease from baseline to six months (P = 0.04). These results indicate that Group A benefited more from the treatment compared to Group B across several periodontal health indicators. DISCUSSION Aggressive periodontitis (AgP) is marked by rapid periodontal attachment and bone loss in young, systemically healthy individuals, primarily associated with the bacteria Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis.[12] These pathogens produce virulence factors, such as lipopolysaccharides (LPS), which contribute to inflammation and tissue destruction by promoting osteoclastogenesis and bone resorption.[3] This study evaluated endotoxin levels in gingival crevicular fluid (GCF) and peripheral blood of 24 subjects—12 with generalized aggressive periodontitis (GAgP) and 12 periodontally healthy controls. Significant differences in clinical parameters, such as probing pocket depth and clinical attachment levels, were observed at baseline between the groups, with Group A exhibiting higher values.[4] In GCF, baseline endotoxin levels were significantly higher in GAgP patients (Group A) compared to healthy controls (Group B), reflecting the increased presence of periodontopathogenic bacteria in the periodontal pockets.[5] Posttreatment, Group A showed a significant reduction in GCF endotoxin levels, highlighting the effectiveness of periodontal therapy in mitigating bacterial load and disease severity. However, endotoxin levels in peripheral blood did not show a significant difference between the groups at baseline or after treatment, suggesting that the systemic dissemination of endotoxins from periodontal sites might be limited.[6] The findings align with previous studies, indicating that while periodontal treatment effectively reduces local endotoxin levels, its impact on systemic endotoxin levels is minimal. This underscores the complexity of the inflammatory response in periodontal disease and its potential systemic implications. Further large-scale research is needed to explore the relationship between local periodontal inflammation and systemic inflammatory mediator levels, contributing to a better understanding of periodontal disease’s role in systemic health. CONCLUSION The study concluded that there was a significant reduction in probing pocket depth, clinical attachment level, plaque index, and gingival index in generalized aggressive periodontitis (GAgP) cases six months after periodontal surgical therapy. These findings suggest that detecting bacterial endotoxins in GCF could be crucial for early disease diagnosis and understanding disease mechanisms in GAgP, though further long-term studies with larger populations are needed to confirm these results. Conflicts of interest There are no conflicts of interest.